BICO Group AB (publ) has repurchased convertible bonds to a total nominal amount of SEK 98m
August 18, 2025 6:00 pmOn March 19, 2021, BICO Group AB (publ) (“BICO” or the “Company”) issued senior unsecured convertible bonds with a total nominal amount of SEK 1,500,000,000 (the “Convertible Bonds”).
On August 18, 2025, the Company repurchased Convertible Bonds with a total nominal amount of SEK 98,000,000 at a purchase price of 96.52 percent (excluding accrued but unpaid interest) of the Convertible Bond’s nominal amount. The total purchase consideration for the bought-back Convertible Bonds thereby amounted to SEK 94,589,600 (the “Buyback”). Following the Buyback, and together with the Convertible Bonds repurchased by BICO on November 22, 2024, and February 18, 2025, respectively (as separately communicated), the total nominal amount of repurchased Convertible Bonds by BICO totals SEK 492,000,000 leaving SEK 1,008,000,000 in Convertible Bonds outstanding.
The rationale behind the Buyback was to optimize BICO’s capital structure i.e., and further reduce long-term debt.
BICO will continue to evaluate the bond market and may from time to time repurchase further Convertible Bonds in the market, subject to the liquidity needs of the Company.
The Buyback was conducted through a safe harbour approach with DNB Carnegie Investment Bank AB (publ) as Dealer Manager.
For further information, please contact:
Jacob Thordenberg, CFO, BICO Group AB
Phone: +46 735 34 88 84
E-mail: jt@bico.com
The information was submitted for publication, through the agency of the contact person set out above, on August 18, 2025 at 6pm CEST.
About BICO
BICO is a lab automation partner and provider of selected workflows to pharma and biotech. With 48,000+ instruments installed in over 65 countries, BICO products, software, and solutions are found in more than 3,500 laboratories, including the world’s top 20 pharmaceutical companies, and have been cited in over 10,900 publications. Operating through two business areas – Lab Automation and Life Science Solutions – BICO strives towards the vision to enable and automate the life science lab of the future. BICO is listed on Mid-Cap, Nasdaq Stockholm under BICO. www.bico.com